Celltex Therapeutics Corporation Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Therapy Services
  • Stem Cell Banking
  • The Celltex Difference
  • How It Works
  • Our Science & Lab
  • View Clinical Trials
  • Conditions, Disorders & Diseases
  • Frequently Asked Questions
  • News & Press
  • Client Results
  • Client Stories
  • Client Assessment
  • Attend a Webinar
  • View our Online Webinar
  • View More

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.

Celltex Therapeutics Corporation Logo Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Products & Services
    • Therapy
    • Stem Cell Banking
    • The Celltex Difference
  • How It Works
    • How It Works
    • Our Science & Lab
    • Conditions, Disorders & Diseases
  • Results
    • Clinical Trials
    • Client Results
    • Client Stories
  • Resources
    • Stem Cell 101
    • Attend a Webinar
    • View Previous Webinars
    • Request Information
    • Client Assessment
    • Extraction Sites
    • For Physicians
    • Company Information
    • Careers
  • FAQs
  • News

Category: Press Releases & Company Updates

Company Update

Celltex Celebrates Jackie Sherrill’s Induction into the Alabama Sports Hall of Fame

May 15, 2023

Celltex is proud to announce Jackie Sherrill, Celltex Sports Program Manager, and legendary collegiate football coach is being inducted into the Alabama Sports Hall of Fame. Sherrill’s induction stems from numerous accolades gained across his 37-year coaching career, most notably as the head football coach at Washington State University, University of Pittsburgh, Texas A&M University and Mississippi State University.

Learn More
Company Update

Maxine Snapka Becomes First Celltex Client to Celebrate 100 Years

January 20, 2023

Long-time Celltex client Maxine Snapka celebrated her 100th birthday, becoming the first centenarian working with Celltex to keep living life well regardless of age. Inspired by her dedication to health and wellness, Celltex celebrated her achievement by awarding her the first-ever Celltex Centenarian Award.

Learn More
Company Update

Andrews Medicine and Celltex Therapeutics Corporation Join Forces to Bring Cutting Edge Technologies to Athletic Injuries

October 4, 2022

James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries.

Learn More
Company Update

Legendary Football Coach and Celltex Sports Program Manager Inducted to Pitt Athletics Hall of Fame 2020 Class

October 29, 2021

Learn More
Company Update

Celltex on Talking with Tony Buzbee KSEV Radio Show

July 22, 2020

Learn More
Company Update

Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using Mesenchymal Stem Cells (MSCs) as a Prophylactic Against COVID-19

July 1, 2020

Learn More
Company Update

Rick Perry Discusses Celltex’s COVID-19 Clinical Trials on Fox News TV

June 30, 2020

Former U.S. Secretary of Energy and former Governor of Texas, Rick Perry, was on Fox News TV discussing Celltex’s COVID-19 ongoing clinical trials and the ingenuity that will deliver a victory over this virus.

Learn More
Company Update

Celltex & COVID-19 Clinical Trials

June 29, 2020

Celltex has three ongoing COVID-19 clinical trials using Celltex’s TRUECELL™ Mesenchymal Stem Cells (MSCs), a Phase III and two Phase II.

Learn More
Company Update

Celltex has submitted Emergency Expanded Access Clinical Study for Subjects with Coronavirus 2019 (COVID-19) using multiple dose Infusions of Autologous Adipose-Tissue Derived Mesenchymal Stem Cells (ADMSCs)

April 2, 2020

The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. On March 21st, 2020, Celltex submitted an emergency expanded access clinical study to the United States Food and Drug Administration (FDA) that would allow patients with COVID-19 to receive infusions of autologous Adipose-tissue derived Mesenchymal Stem Cells (AdMSCs) in the US.

Learn More
Company Update

Aging & Disease Reports Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia

March 25, 2020

The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China.

Learn More

Posts navigation

Older posts

Recent Posts

  • Exploring Regenerative Medicine Beyond Stem Cell Therapy March 24, 2025
  • What Makes MSCs So Promising? A Deep Dive on Mesenchymal Stem Cells January 15, 2025
  • Stem Cell Therapy: How Are MSCs Administered to the Body? December 12, 2024
  • The Bryan-College Station Eagle: Celltex’s Jackie Sherrill Featured as a Guest Columnist to Comment on the Upcoming Texas A&M vs. Texas Game November 27, 2024
  • The Difference Between Cord Blood Banking and Adult Stem Cell Banking November 20, 2024
Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

About

  • Company Information
  • About Celltex
  • Board of Directors
  • Executive Team
  • Client Services Team
  • Celltex Mexico
  • Site Map
  • News & Press
  • Careers

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.